US Health Costs Hit $6 Trillion as Price Opacity Drives 2027 Premium Spikes

Key points

• US health spending is on track to surpass $6 trillion in 2026, equating to approximately $16,500 per person.
• Employer health costs are projected to rise by 8.2% to 11.1% in 2027, the largest increase since 2003.
• Hospitals often charge commercial insurers two to three times more than Medicare for identical services, such as joint replacements and colonoscopies.
• GLP-1 weight-loss drugs account for roughly 1 percentage point of employer cost growth, with drug spending rising from 18% to 23% of premiums since 2021.
• A bipartisan bill, the Patients Deserve Price Tags Act, seeks to mandate public posting of actual negotiated rates to end price opacity.
• ACA marketplace premiums are expected to rise by a median of 15% in 2027, following an 18% increase in 2026.

Background

This surge follows a period of relative moderation in health spending growth, though baseline costs remain high. Recent developments include the expansion of Trump’s most-favored-nations drug pricing for Medicaid and mixed results from the TrumpRx platform. Earlier reports indicated that employer costs were already rising due to GLP-1 uptake and AI-based billing disputes, setting the stage for the current crisis in affordability.

How outlets are covering it

STAT and researchers like Gerard Anderson argue that price, not volume, is the primary driver of high costs, noting that hospitals exploit market power to charge multiples of Medicare rates. Conversely, the American Hospital Association and industry lobbyists contend that rising volume and sicker patients are the main culprits, though federal data shows a 3.4% price increase in 2024. CNBC highlights GLP-1 drugs and inflation as key drivers, while The Topeka Capital-Journal emphasizes the lack of price transparency, citing a case where a CT scan bill jumped from an estimated $200 to $6,293. Insurers are criticized for failing to negotiate effectively, acting as 'turnstiles' rather than guardians of the health care dollar.

Why it matters

Soaring premiums and deductibles are straining household budgets and threatening the viability of employer-based insurance. As costs rise, workers face higher out-of-pocket expenses, potentially leading to delayed care and increased medical debt. The issue has become a major political factor in the 2026 midterm elections, with voters expressing frustration over affordability and a lack of control over their health care costs.

What to watch

States like Indiana and Delaware have already passed price control measures, and more states may follow as employers push for regulation. The Patients Deserve Price Tags Act aims to force transparency in negotiated rates. Employers are increasingly considering dropping GLP-1 coverage or switching carriers to manage costs. If current trends continue, 2027 could see the largest premium hikes in decades, potentially accelerating the shift toward state-level price caps and reference-based pricing models.